Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Bridgebio Pharma, Inc. (BBIO)  
$28.50 0.60 (2.06%) as of 4:30 Mon 5/13


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 173,970,000
Market Cap: 4.96(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $13.29 - $43.89
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   BridegeBio Pharma identifies and improves medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Co.'s pipeline are: Acoramidis/AG10/BBP-265, a small molecule transthyretin (TTR) stabilizer for the treatment of TTR amyloidosis; Infigratinib/BBP-831, an oral FGFR1-3 selective tyrosine kinase inhibitor for the treatment of achondroplasia; BBP-631, a preclinical adeno-associated virus gene transfer for the treatment of congenital adrenal hyperplasia; and Encaleret, a small molecule antagonist of the calcium sensing receptor for the treatment of Autosomal Dominant Hypocalcemia Type 1.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 5,415 192,897 1,845,608 2,886,602
Total Sell Value $195,041 $7,018,061 $62,779,686 $73,415,196
Total People Sold 2 5 6 6
Total Sell Transactions 2 10 16 29
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 288
  Page 7 of 12  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Kumar Neil CEO and President   •       •      –    2020-11-16 4 OE $0.00 $0 D/D 5,129 4,694,209     -
   Henderson Michael Thomas Chief Business Officer   •       –      –    2020-11-16 4 D $44.33 $281,628 D/D (6,353) 274,211     -
   Henderson Michael Thomas Chief Business Officer   •       –      –    2020-11-16 4 OE $0.00 $10,500 D/D 22,813 280,564     -
   Henderson Michael Thomas Chief Business Officer   •       –      –    2020-11-16 4 AS $45.00 $450,000 D/D (10,000) 267,751 29%     
   Cook Jennifer E. Director   –       •      –    2020-11-16 4 OE $0.00 $0 D/D 3,576 3,576     -
   Sinha Uma Chief Scientific Officer   •       –      –    2020-11-16 4 OE $0.00 $0 D/D 469 16,460     -
   Mccormick Frank Chairman of Oncology   •       –      –    2020-11-13 4 S $42.22 $4,275,769 D/D (100,000) 1,200,468 -40%     
   Turtle Cameron See Remarks   •       –      –    2020-11-05 4 AS $42.05 $105,125 D/D (2,500) 12,568 55%     
   Turtle Cameron See Remarks   •       –      –    2020-11-05 4 OE $17.00 $42,500 D/D 2,500 15,068     -
   Henderson Michael Thomas Chief Business Officer   •       –      –    2020-11-02 4 AS $38.33 $383,558 D/D (10,000) 267,751 81%     
   Henderson Michael Thomas Chief Business Officer   •       –      –    2020-11-02 4 OE $1.05 $10,500 D/D 10,000 277,751     -
   Homcy Charles J Chairman of Pharmaceuticals   •       •      –    2020-10-16 4 AS $41.00 $420,496 D/D (10,256) 1,203,767 73%     
   Homcy Charles J Chairman of Pharmaceuticals   •       •      –    2020-10-16 4 OE $17.00 $174,352 D/D 10,256 1,214,023     -
   Henderson Michael Thomas Chief Business Officer   •       –      –    2020-10-01 4 AS $38.29 $388,342 D/D (10,000) 267,751 70%     
   Henderson Michael Thomas Chief Business Officer   •       –      –    2020-10-01 4 OE $0.28 $7,994 D/D 10,000 277,751     -
   Turtle Cameron See Remarks   •       –      –    2020-09-30 4 AS $37.59 $546,458 D/D (14,500) 12,568 84%     
   Turtle Cameron See Remarks   •       –      –    2020-09-30 4 OE $0.16 $45,500 D/D 14,500 27,068     -
   Homcy Charles J Chairman of Pharmaceuticals   •       •      –    2020-09-30 4 AS $38.00 $380,000 D/D (10,000) 1,203,767 84%     
   Homcy Charles J Chairman of Pharmaceuticals   •       •      –    2020-09-30 4 OE $17.00 $170,000 D/D 10,000 1,213,767     -
   Homcy Charles J Chairman of Pharmaceuticals   •       •      –    2020-09-29 4 AS $37.50 $682,500 D/D (18,200) 1,203,767 84%     
   Homcy Charles J Chairman of Pharmaceuticals   •       •      –    2020-09-25 4 AS $36.68 $2,985,455 D/D (81,057) 1,221,967 97%     
   Turtle Cameron See Remarks   •       –      –    2020-09-18 4 AS $42.01 $105,024 D/D (2,500) 12,568 36%     
   Turtle Cameron See Remarks   •       –      –    2020-09-18 4 OE $17.00 $42,500 D/D 2,500 15,068     -
   Henderson Michael Thomas Chief Business Officer   •       –      –    2020-09-18 4 AS $40.00 $400,000 D/D (10,000) 267,751 36%     
   Henderson Michael Thomas Chief Business Officer   •       –      –    2020-09-18 4 OE $0.16 $2,212 D/D 10,000 277,751     -
  288 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 7 of 12
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us